Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (22 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net sales
198
256
273
263
353
320
298
Cost of sales
131
188
196
187
250
211
182
Gross Profit
67
68
77
76
103
109
116
Distribution expenses
19
29
27
30
50
49
37
Selling, general and administrative expenses
21
22
25
29
38
37
49
Restructuring charges
0
0
0
0
6
1
2
Realignment charges.
0
0
0
0
5
6
0
Operating Income
27
17
25
17
4
17
28
Interest income
0
0
0
0
0
0
0
Interest expense, net
-2
-2
-2
-2
-3
-1
-1
Gain on purchase of NFC
0
0
0
0
0
0
2
Gain (loss) on sale of business non-operating.
0
0
0
0
0
5
0
Other non-operating expense
0
0
0
0
0
-1
0
Other, net
0
0
0
0
-1
0
0
Total other income/(expense), net
-2
-3
-2
-2
-4
2
1
Income from continuing operations before income taxes
24
14
23
15
0
19
28
Provision for income taxes
-9
-5
-9
-6
-1
-7
-10
Income/(loss) from continuing operations
15
9
14
9
0
0
0
Loss from discontinued operations, before income taxes
0
1
-1
0
0
0
0
Income tax benefit
0
0
0
0
0
0
0
Loss from discontinued operations
0
0
0
0
0
0
0
Net income/(loss)
15
10
14
9
-1
12
19
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Oct 28, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Oct 14, 2016 n/a
calculated values,
restated on Oct 14, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (35 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
2
2
14
19
8
12
Trade, net of allowances
n/a
36
29
42
40
37
33
Other accounts receivable net current.
n/a
3
1
4
2
4
6
Inventories, net
n/a
42
41
53
45
42
37
Current deferred tax assets
n/a
1
1
1
2
3
0
Prepaid expenses and other
n/a
2
2
4
3
4
7
Total current assets
n/a
86
76
119
112
97
95
Property, plant and equipment, net
n/a
72
68
97
92
81
80
Deferred tax assets
n/a
1
1
1
0
0
0
Goodwill
n/a
4
4
11
13
22
22
Intangible assets, net
n/a
19
15
29
28
37
34
Restricted cash
n/a
0
1
1
1
1
1
Other assets, net
n/a
3
3
4
4
5
5
Total assets
n/a
185
168
262
251
242
237
Liabilities and owners' equity
Accounts payable
n/a
25 24899000
22 21855000
35 35492000
37 36690000
36 35980000
26 26418000
Accrued liabilities
n/a
4 3921000
5 4595000
8 8362000
17 16986000
10 9602000
11 11252000
Book overdraft
n/a
3 2852000
0 0
0 0
0 0
0 0
0 0
Current deferred tax liabilities
n/a
0 7000
0 0
0 0
0 0
0 0
0 0
Current maturities of long-term debt
n/a
8 8000000
0 0
0 0
0 0
0 0
0 0
Employee incentive accrual
n/a
1 1103000
2 2227000
2 1989000
5 4575000
5 4852000
6 5999000
Total current liabilities
n/a
41 40782000
29 28677000
46 45843000
58 58251000
50 50434000
44 43669000
Long-term debt
n/a
41 41279000
24 24000000
85 85000000
60 60000000
53 53000000
36 35800000
Deferred tax liabilities
n/a
5 5381000
7 7046000
11 11462000
10 9881000
13 13075000
10 9948000
Other long-term liabilities
n/a
1 1406000
1 1200000
2 2470000
3 2520000
2 2429000
4 4422000
Total liabilities
n/a
89 88848000
61 60923000
145 144775000
131 130652000
119 118938000
94 93839000
Commitments and contingencies
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Preferred stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
0 113000
0 114000
0 115000
0 116000
0 117000
0 119000
Additional paid-in capital
n/a
25 25256000
26 26022000
27 26689000
29 28886000
32 31676000
37 36553000
Accumulated other comprehensive income/(loss)
n/a
-1 -1233000
-4 -4339000
-3 -2504000
1 645000
-10 -9667000
-12 -12047000
Retained earnings
n/a
72 72394000
85 84970000
93 92940000
91 90559000
101 101295000
119 118564000
Total stockholders’ equity
n/a
97 96530000
107 106767000
117 117240000
120 120206000
123 123421000
143 143189000
Total liabilities and stockholders’ equity
n/a
185 185378000
168 167690000
262 262015000
251 250858000
242 242359000
237 237028000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Oct 14, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (43 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net income/(loss)
15
10
14
9
-1
12
19
Depreciation and amortization
7
7
7
8
14
14
15
Non cash restructuring and realignment charges.
0
0
0
0
4
6
0
Non-cash impairment charges
0
0
0
0
3
0
0
Amortization of loan costs included in interest expense
0
0
0
0
0
0
0
Stock-based compensation expense
1
1
1
0
2
3
5
Bad debt expense
0
0
0
0
0
0
0
Inventory valuation adjustment charges to costs and expenses.
0
0
0
0
1
1
0
Gain (loss) on sale of business non-operating.
0
0
0
0
0
-5
0
Gain on purchase of NFC
0
0
0
0
0
0
-2
(Gain) loss on disposal of property
0
0
0
0
0
0
0
Deferred income tax expense/(benefit)
2
2
1
1
-2
-4
0
Other
0
0
0
0
0
0
0
Tax benefit from stock-based awards
0
0
0
-1
0
0
0
Accounts receivable — trade
-9
-6
7
2
2
1
5
Accounts receivable — other
-1
-1
2
-3
1
-2
-2
Inventories
-4
-2
-6
-1
8
-1
4
Other current and non-current assets
0
-1
0
-1
1
-1
1
Accounts payable
4
4
-3
5
0
1
-9
Accrued liabilities and other
0
0
2
-1
8
-8
4
Net cash provided by operating activities
15
13
25
20
40
18
41
Additions to property, plant and equipment
-3
-8
-5
-6
-9
-14
-14
Cash used in connection with General Chemical acquisition
-27
0
0
0
0
0
0
Disposals of property, plant and equipment
0
0
0
0
0
3
0
Change in restricted cash
0
0
-1
0
0
0
0
Acquisition of Ultra Pure Chemicals, net of cash acquired
0
0
0
-63
0
-22
0
Proceeds from sale of creosote distribution business.
0
0
10
0
0
15
0
Net cash used in investing activities
-30
-8
4
-68
-9
-18
-17
Net borrowings/(payments) under revolving loan facility
0
-2
-14
61
-25
-40
0
Deferred financing costs
0
0
0
0
0
-1
0
Proceeds from borrowing under New Credit Facility
0
0
0
0
0
59
3
Net payments under New Credit Facility
20
0
0
0
0
-6
-20
Principal payments on borrowings on term loan
-7
-8
-11
0
0
-20
0
Book overdraft
0
3
-3
0
0
0
0
Tax benefit from stock-based awards
0
0
0
1
0
0
0
Proceeds from exercise of stock options and warrants
0
0
0
0
0
0
0
Payment of dividends
-1
-1
-1
-1
-1
-1
-1
Net cash provided by/(used in) financing activities
13
-8
-29
60
-26
-9
-19
Effect of exchange rate changes on cash
0
0
0
0
0
-2
-1
Net increase (decrease) in cash and cash equivalents
-2
-3
0
12
5
-12
5
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Oct 28, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Oct 14, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,